Literature DB >> 30551877

YY1 negatively regulates the XAF1 gene expression in prostate cancer.

B Camacho-Moctezuma1, M Quevedo-Castillo1, J Melendez-Zajgla2, G Aquino-Jarquin3, G U Martinez-Ruiz4.   

Abstract

XAF1 is a tumor suppressor gene with low or absent expression in cancer. Since transcriptional reactivation or ectopic-mediated expression of XAF1 inhibits tumor growth, it is of great interest to elucidate the molecular mechanisms leading to XAF1 silencing. YY1 is a transcription factor that acts as a repressor or an activator to modulate several cancer-associated cellular processes. Both YY1 and XAF1 have key roles in prostate cancer (PCa) progression and are associated with worse clinical outcomes. To assess whether YY1 regulates the transcriptional activation of the XAF1 gene, we performed gene-reporter assays coupled with site-directed mutagenesis, which showed that YY1 is able to mediate XAF1 silencing. Concordantly, ChIP-qPCR assays showed that YY1 interacts with the XAF1 promoter in PC3 cells that lacks XAF1 expression. This association was lost after exposure to epigenetic modulators that induce XAF1 expression. Further supporting the YY1's repressive role, we found transcriptional reactivation of the XAF1 gene by YY1 downregulation. As expected by previous reports showing that HDAC1 is needed for YY1-mediated repressive actions, we observed XAF1 re-expression after either inhibition or downregulation of the HDAC1 gene. Finally, expression data retrieved from the TCGA consortium showed that PCa samples presented lower XAF1 and higher HDAC expression levels than normal tissues. Thus, our results support a model in which YY1 is able to silence tumor suppressor genes such as XAF1 through HDAC1 in PCa.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; HDAC1; Prostate; Transcriptional regulation; XAF1 promoter; YY1

Mesh:

Substances:

Year:  2018        PMID: 30551877     DOI: 10.1016/j.bbrc.2018.12.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  YY1 promotes colorectal cancer proliferation through the miR-526b-3p/E2F1 axis.

Authors:  Zejun Fang; Hua Yang; Dan Chen; Xiaoying Shi; Qinqiu Wang; Chaoju Gong; Xi Xu; Hong Liu; Min Lin; Junxiao Lin; Chengfu Xu; Jimin Shao
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

2.  Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications.

Authors:  Aida Barreiro-Alonso; María Cámara-Quílez; Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; Olaia Martínez-Iglesias; Angélica Figueroa; María-Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2019-11-05       Impact factor: 6.639

3.  Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma.

Authors:  Can Luo; Xin Chen; Yuting Bai; Lei Xu; Shuqi Wang; Lihua Yao; Xiaolan Guo; Dongsheng Wang; Xiaowu Zhong
Journal:  Int J Genomics       Date:  2022-03-20       Impact factor: 2.326

Review 4.  Epigenetic mechanisms underlying prostate cancer radioresistance.

Authors:  Catarina Macedo-Silva; Rosaria Benedetti; Fortunato Ciardiello; Salvatore Cappabianca; Carmen Jerónimo; Lucia Altucci
Journal:  Clin Epigenetics       Date:  2021-06-08       Impact factor: 6.551

Review 5.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

6.  The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.

Authors:  Pei Xu; Haibo Xiao; Qi Yang; Rui Hu; Lianyong Jiang; Rui Bi; Xueyan Jiang; Lei Wang; Ju Mei; Fangbao Ding; Jianbing Huang
Journal:  Exp Mol Med       Date:  2020-01-20       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.